The clinical impact of molecular breast imaging in women with proven invasive breast cancer scheduled for breast-conserving surgery.

Purpose: To investigate the clinical utility of molecular breast imaging (MBI) in patients with proven invasive breast cancer scheduled for breast-conserving surgery (BCS).

Methods: Following approval by the institutional review board and written informed consent, records of patients with newly diagnosed breast cancer scheduled for BCS who had undergone MBI for local staging in the period from March 2012 till December 2014 were retrospectively reviewed.

Results: A total of 287 women (aged 30-88 years) were evaluated.